MTOR and Alzheimer disease: Activating autophagy by rapamycin treatment, an inhibitor of mTOR pathway, protects neuroblastoma cells from Aβ toxicity [64], reduces cerebral Aβ load and slows AD progression in a transgenic AD mouse model [65].